← All stocks

COMPUGEN LTD

CGEN No buying or selling

CIK 0001119774 #3768 in the set updated 20 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

10 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Silberman David

Chief Financial Officer

—

55,000

$137.50K

+54.9%

Levine Zurit

SVP, Business Development

—

47,375

$118.44K

+61.3%

Kredo Russo Sharon

SVP, Research & Discovery

—

37,500

$93.75K

+92.3%

Mahler Michelle

Chief Medical Officer

—

36,625

$91.56K

+58.4%

Livnat Savitzky Kinneret

Director

—

20,850

$52.13K

+56.2%

ZWEIFACH SANFORD S

Director

—

20,180

$50.45K

+59.1%

Halevy Gilead

Director

—

18,907

$47.27K

+65.7%

Perry Eran

Director

—

17,500

$43.75K

+75.0%

Hukkelhoven Mathias

Director

—

17,500

$43.75K

+75.0%

Ophir Eran

President and CEO

—

11,375

$28.44K

0.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 30 Mar 2026